This page last modified on Wednesday, Oct 26, 2011
SUBOXONE is the first opiod medication approved under DATA 2000 for the treatment of opiod dependence in an office-based setting. SUBOXONE also can be dispensed for take-home use, just as any other medicine for other medical conditions.
The primary active ingredient in SUBOXONE is buprenorphine. Because buprenorphine is a partial opioid agonist, its opioid effects are limited compared with those produced by full opioid agonists, such as oxycodone or heroin. Suboxone also contains naloxone, an opioid antagonist. The naloxone in Suboxone is there to discourage people from dissolving the table and injecting it. When Suboxone is placed under the tongue, as directed, very little nalaxone reaches the bloodstream, so what the patient feels are the effects of the buprenorphine. However, if the naloxone is injected, it can cause a person dependent on a full opioid agonist to quickly go into withdrawal.
To learn more about Suboxone or how to enroll in the program, including requirements and costs, you may contact the Mason City Clinic Psychiatry:
When calling to schedule an appointment, please be sure to reference that your call is in regards to Suboxone so the Mason City Clinic will allow for the appropriate time needed.
Dr. Rogerio Ramos, MD, is a board-certified Psychiatrist specializing in addictions. The goal of his clinic is to provide humane and effective treatment for those clients struggling with opiod/opiate dependence.